Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by TriumphSpitSixon Nov 02, 2018 6:22pm

181 Views

Post# 28917545

RE:RE:RE:RE:Q:

Low 20s would truly be a Christmas present!

Jefferam1 wrote: I agree with you 100%.
Typically I factor in some delay time and then post it, then people shout at me for being too pestimistic. Followed by reality when I still didn't even add enough delay time and things take longer then even I guessed. And by this point, no one seems to come back and say I was right to add that delay time... i digress.

In this case I did not add any delay time which i knew wouldn't be accuate but generally my comments had the right message.

Part of the reason I didn't factor that in was because I was typing that I expect Part 2 results to actually come out in Q3 2019 but figured I'd get barked so I just let it be. I agree Part 1 will likely go into Juanuary which could present a buying opportunity in Dec as price drops due to warrants and then tax loss and catalyst to save it. I won't be surprised if we see low 20s in Nov/Dec. Not banking on it but would not rule it out.